A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2001
10/25/2001	WO2001078748A2 Immunomodulatory methods using carbohydrate antigens
10/25/2001	WO2001078702A2 Methods and compositions for modulating alpha adrenergic receptor activity
10/25/2001	WO2001078700A2 Compositions for use in modulating immune system function comprising at least one retrinoid and at least one cytokine
10/25/2001	WO2001078697A2 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
10/25/2001	WO2001078655A2 Methods and compositions for heat shock protein mediated immunotherapy of melanoma
10/25/2001	WO2001078653A2 Graft rejection inhibition with ccr2 inhibitors
10/25/2001	WO2001078649A2 Pharmaceutical curative compound
10/25/2001	WO2001049317A9 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen
10/25/2001	WO2001044246A8 Bicyclic inhibitors of glycogen synthase kinase 3
10/25/2001	WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001	WO2001027113A3 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES
10/25/2001	WO2001026679A3 T-cells and molecules involved in immune regulation
10/25/2001	WO2001025238A3 Heterocyclic compounds useful as inhibitors of tyrosine kinases
10/25/2001	WO2001022993A3 MUCOSAL DTPa VACCINES
10/25/2001	WO2001012790A3 Isomerase proteins
10/25/2001	WO2000062788A9 Treatment of hypersensitivity reaction disorders
10/25/2001	WO2000056737A9 Calanolides for inhibiting btk
10/25/2001	WO2000011169A3 Human cell signaling proteins (csig)
10/25/2001	US20010034452 Epothilons C and D, preparation and compositions
10/25/2001	US20010034362 Pyrrolidine derivatives for vision and memory disorders
10/25/2001	US20010034348 Nitric oxide synthase inhibitor; nervous system disorders
10/25/2001	US20010034340 Hormone replacement therapy
10/25/2001	US20010034331 Isolated polypeptide
10/25/2001	US20010034324 Immunostimulation
10/25/2001	US20010034062 For engineering cells for delivery of antibodies to combat respiratory diseases, viral infection, asthma, allergy, and macular degeneration
10/25/2001	US20010034051 For example: (2-(3-amino-4-nitrophenyl)amino)ethyl)(6-(2,4-dichlorophenyl-5-nitropyrazin -2-yl)-amine; antidiabetic, -carcingenic and ischemic agents; nervous and cardiovascular system disorders; immunotherapy; obesity; syndromes
10/25/2001	US20010033836 Transgenic autologous T-cell therapy in humans, and related compositions and kits
10/25/2001	US20010033834 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
10/25/2001	US20010032643 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage
10/25/2001	DE10018681A1 Composition for autologous tumor treatment, comprises extracellular material produced by culturing immune competent cells with tumor cells that lack membrane surface substances
10/25/2001	CA2747325A1 Albumin fusion proteins
10/25/2001	CA2407531A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
10/25/2001	CA2406955A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001	CA2406472A1 Javelinization of protein antigens to heat shock proteins
10/25/2001	CA2406390A1 Cloning, overexpression and therapeutic uses of bioactive histidine ammonia lyase
10/25/2001	CA2406378A1 Targeted vaccine delivery systems
10/25/2001	CA2406245A1 Il-174 uses, compositions and methods
10/25/2001	CA2406220A1 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease
10/25/2001	CA2406190A1 Screening method for compounds
10/25/2001	CA2405781A1 Secreted proteins
10/25/2001	CA2405709A1 Albumin fusion proteins
10/25/2001	CA2405701A1 Albumin fusion proteins
10/25/2001	CA2405563A1 Albumin fusion proteins
10/25/2001	CA2405557A1 Albumin fusion proteins
10/25/2001	CA2405555A1 Pluripotent cells comprising allogenic nucleus and mitochondria
10/25/2001	CA2405550A1 Albumin fusion proteins
10/25/2001	CA2405525A1 Albumin fusion proteins
10/25/2001	CA2405451A1 Molecules associated with human reproduction
10/25/2001	CA2405233A1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
10/25/2001	CA2403644A1 Drug metabolizing enzymes
10/25/2001	CA2403490A1 N-substituted dithiocarbamates for the treatment of biological disorders
10/25/2001	CA2399940A1 Enhancement of antibody-mediated immune responses
10/25/2001	CA2396762A1 Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21
10/24/2001	EP1148059A1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
10/24/2001	EP1147214A1 A novel method for designing protein kinase inhibitors
10/24/2001	EP1147212A1 T helper cell epitopes
10/24/2001	EP1147190A1 Her-2/neu fusion proteins
10/24/2001	EP1147178A1 Production of biomedical peptides and proteins in plants using transcomplementation systems
10/24/2001	EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
10/24/2001	EP1147131A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
10/24/2001	EP1147119A1 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
10/24/2001	EP1147117A1 Immunological adjuvant compounds
10/24/2001	EP1147108A1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
10/24/2001	EP1147107A1 Novel angiogenesis inhibitors
10/24/2001	EP1147104A1 Aromatic heterocyclic compounds as antiinflammatory agents
10/24/2001	EP1147102A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001	EP1147097A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
10/24/2001	EP1147095A1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
10/24/2001	EP1147091A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/24/2001	EP1147089A1 Phenylphenanthridines with pde-iv inhibiting activity
10/24/2001	EP1147088A1 6-arylphenanthridines with pde-iv inhibiting activity
10/24/2001	EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/24/2001	EP1147078A1 Acetylenic (beta)-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001	EP1146907A2 Use of cationic lipids to generate anti-tumor immunity
10/24/2001	EP1146906A1 Mucosal delivery system
10/24/2001	EP1146902A1 Treatment of autommune diseases by an agonistic cd40-binding protein
10/24/2001	EP1146894A1 Uses of thank, a tnf homologue that activates apoptosis
10/24/2001	EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response
10/24/2001	EP1146888A2 Specific therapeutic interventions obtained by interference with redistribution and/or targetting
10/24/2001	EP1146885A1 Pre-conditioning against cell death
10/24/2001	EP1146883A1 Modulation of immune response by ribavirin
10/24/2001	EP1146874A1 Vitronectin receptor antagonist
10/24/2001	EP1146870A1 Antioxidant compositions and methods for companion animals
10/24/2001	EP1146858A1 Non-invasive vaccination through the skin
10/24/2001	EP1146845A2 Compressed lecithin preparations
10/24/2001	EP1146790A1 Compounds and methods
10/24/2001	EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
10/24/2001	EP0910405B1 Vaccine containing caprine arthritis-encephalitis virus and use for immunoprotection against hiv-1 infection
10/24/2001	EP0869955B1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/24/2001	EP0828511B1 Haemophilus influenzae type b vaccine composition containing polyribosylribitol phosphate and method for making the same
10/24/2001	EP0820433B1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
10/24/2001	EP0801686B1 Process for preparing cyclosporin a
10/24/2001	EP0755393B1 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4- 3-(1-methylethylamino)-2-pyridinyl]piperazine
10/24/2001	CN1319139A Polynucleotide constructs and uses thereof
10/24/2001	CN1319137A Keratinocyte derived interferon
10/24/2001	CN1319133A Short peptides which selectively modulate activity of protein kinases
10/24/2001	CN1319097A Benzoxazine and benzothiazine derivatives and their use in medicines
10/24/2001	CN1319096A Quinazoline derivatives and pharmaceutical applications thereof
10/24/2001	CN1319095A Imidazole compounds and their use as adenosine deaminase inhibitors
10/24/2001	CN1319094A Imidazolyl derivatives

1 ... 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 ... 1172